MFG
XERS icon

Merit Financial Group’s Xeris Biopharma Holdings XERS Stock Holding History

Merit Financial Group’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81.5K Buy
+10,289
New +$65.7K ﹤0.01% 2247

Other funds holding XERS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Merit Financial Group's XERS Position: Q2 2026 in Review

Merit Financial Group opened a new position in Xeris Biopharma Holdings (XERS) in Q2 2026: 10,289 shares worth $81.5K. The stake represents ﹤0.01% of the portfolio and ranks #2247 among its holdings.

18 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Merit Financial Group held 10,289 shares of Xeris Biopharma Holdings worth $81.5K as of Q2 2026.
  • Xeris Biopharma Holdings was a new Merit Financial Group position in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Merit Financial Group's portfolio in Q2 2026, its #2247 holding.
  • 18 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.